SOAs

24/09/2020

Statement of Advice (SOA): dupilumab (Dupixent®) 3238

13/11/2020

Statement of Advice (SOA): sofosbuvir (Sovaldi) 4589

18/11/2020

Statement of Advice (SOA) galcanezumab (Emgality) 3788

16/12/2020

Statement of Advice (SOA) caplacizumab (Cablivi) 2953

23/02/2021

Statement of Advice (SOA): pretomanid (Dovprela®) 3342

02/02/2021

Statement of Advice (SOA): lefamulin (Xenleta®) 3123

17/02/2020

Statement of Advice (SOA): anakinra (Kineret) 3734

21/02/2020

Statement of Advice (SOA): lenalidomide (Revlimid) 810

17/05/2021

Statement of Advice (SOA): olaparib (Lynparza) 3262

13/10/2020

Statement of Advice (SOA) teduglutide (Revestive) 905

18/02/2020

Statement of Advice (SOA): budesonide (Jorveza) 2656

27/05/2021

Statement of Advice (SOA): sucroferric oxyhydroxide (Velphoro) 4775

12/10/2021

Statement of Advice (SOA): rituximab (MabThera®) 4446

12/10/2021

Statement of Advice (SOA): fidaxomicin (Dificlir) 2076

12/10/2021

Statement of Advice (SOA): clopidogrel (Plavix) 4823

12/10/2021

Statement of Advice (SOA): tedizolid phosphate (Sivextro) 4603

12/10/2021

Statement of Advice (SOA): sodium oxybate (Xyrem) 3353

27/05/2021

Statement of Advice (SOA): imipenem / cilastatin + relebactam (Recarbrio) 4800

12/10/2021

Statement of Advice (SOA): midostaurin (Rydapt) 3584

12/10/2021

Statement of Advice (SOA): fostemsavir (Rukobia) 2888